Clinical Trial Update: Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating palonosetron alone for preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive non-Hodgkin lymphoma u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Non-hodgkin Lymphoma

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Chemotherapy-Induced Nausea and Vomiting, Non Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED